Retinal Mueller glial cells trigger the hallmark inflammatory process in autoimmune uveitis.
Spontaneous equine recurrent uveitis (ERU) is an incurable autoimmune disease affecting the eye. Although retinal-autoantigen specific T-helper 1 cells have been demonstrated to trigger disease progression and relapses, the molecular processes leading to retinal degeneration and consequent blindness remain unknown. To elucidate such processes, we studied changes in the total retinal proteome of ERU-diseased horses compared to healthy controls. Severe changes in the retinal proteome were found for several markers for blood-retinal barrier breakdown and whose emergence depended upon disease severity. Additionally, uveitic changes in the retina were accompanied by upregulation of aldose 1-epimerase, selenium-binding protein 1, alpha crystallin A chain, phosphatase 2A inhibitor (SET), and glial fibrillary acidic protein (GFAP), the latter indicating an involvement of retinal Mueller glial cells (RMG) in disease process. To confirm this, we screened for additional RMG-specific markers and could demonstrate that, in uveitic retinas, RMG concomitantly upregulate vimentin and GFAP and downregulate glutamine synthetase. These expression patterns suggest for an activated state of RMG, which further downregulate the expression of pigment epithelium-derived factor (PEDF) and begin expressing interferon-gamma, a pro-inflammatory cytokine typical for T-helper 1 cells. We thus propose that RMG may play a fatal role in uveitic disease progression by directly triggering inflammatory processes through the expression and secretion of interferon-gamma.
Hauck
Stefanie M
SM
Institute of Human Genetics, GSF-National Research Center for Environment and Health, Ingolstaedter Landstr. 1, D-85764 Neuherberg, Germany. hauck@gsf.de
Schoeffmann
Stephanie
S
Amann
Barbara
B
Stangassinger
Manfred
M
Gerhards
Hartmut
H
Ueffing
Marius
M
Deeg
Cornelia A
CA
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology / Q000662:veterinary*; D016207:Cytokines / Q000032:analysis; D005136:Eye Proteins / Q000032:analysis; D006734:Horse Diseases / Q000276:immunology*; D006736:Horses / Q000276:immunology*; D007371:Interferon-gamma / Q000032:analysis; D009414:Nerve Growth Factors / Q000032:analysis; D009457:Neuroglia / Q000737:chemistry* / Q000276:immunology; D020543:Proteome / Q000032:analysis*; D012160:Retina / Q000737:chemistry* / Q000276:immunology; D015843:Serpins / Q000032:analysis; D015854:Up-Regulation; D014605:Uveitis / Q000276:immunology / Q000662:veterinary*; D000099174:Pigment Epithelium-Derived Factor
D016207:Cytokines; D005136:Eye Proteins; D007371:Interferon-gamma; D009414:Nerve Growth Factors; D020543:Proteome; D015843:Serpins; D000099174:Pigment Epithelium-Derived Factor